Pa. Starr et al., Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey, CELL TRANSP, 8(1), 1999, pp. 37-45
Current clinical protocols for fetal cell transplantation for Parkinson's d
isease (PD) have focused on restoring dopamine in the striatum. However, th
ere are now a number of human transplant recipients who have had robust inn
ervation of the striatum by dopaminergic grafts (documented by positron emi
ssion tomography or by autopsy), but only a partial improvement in parkinso
nian motor signs. Thus, there is a need for improved transplant strategies.
In animal models of PD, there is recent evidence that restoring dopamine i
n the substantia nigra, instead of or in addition to the striatum, may be i
mportant to correct abnormal motor behavior. This pilot study examined the
morphological features and behavioral effects of fetal dopaminergic neurona
l allografts placed into the substantia nigra of three 1-methyl-4-phenyl-1,
2,3,6-tetrahydropyridine (MPTP)treated hemiparkinsonian rhesus monkeys. We
show that grafts can survive in host substantia nigra. Characteristics of t
he graft-host interface were variable. In one animal, reinnervation of host
substantia nigra was observed, and this animal showed behavioral improveme
nt in a reach-and-retrieval task.